Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/121365
Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
PURPOSE: To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance. METHODS: We screened 673 microRNAs using TaqMan Low-density-Arrays (TLDAs) in tumors from MRCC patients with extreme phenotypes of marked efficacy and resistance to sunitinib, selected from an identification cohort (n = 41). The most relevant differentially expressed microRNAs were selected using bioinformatics-based target prediction analysis and quantified by qRT-PCR in tumors from patients presenting similar phenotypes selected from an independent cohort (n = 101). In vitro experiments were conducted to study the role of miR-942 in sunitinib resistance. RESULTS: TLDAs identified 64 microRNAs differentially expressed in the identification cohort. Seven candidates were quantified by qRT-PCR in the independent series. MiR-942 was the most accurate predictor of sunitinib efficacy (p = 0.0074). High expression of miR-942, miR-628-5p, miR-133a, and miR-484 was significantly associated with decreased time to progression and overall survival. These microRNAs were also overexpressed in the sunitinib resistant cell line Caki-2 in comparison with the sensitive cell line. MiR-942 overexpression in Caki-2 up-regulates MMP-9 and VEGF secretion which, in turn, promote HBMEC endothelial migration and sunitinib resistance. CONCLUSIONS: We identified differentially expressed microRNAs in MRCC patients presenting marked sensitivity or resistance to sunitinib. MiR-942 was the best predictor of efficacy. We describe a novel paracrine mechanism through which high miR-942 levels in MRCC cells up-regulates MMP-9 and VEGF secretion to enhance endothelial migration and sunitinib resistance. Our results support further validation of these miRNA in clinical confirmatory studies.
Matèries (anglès)
Citació
Citació
PRIOR, Celia, PEREZ-GRACIA, Jose luis, GARCIA DONAS, Jesus, RODRIGUEZ-ANTONA, Cristina, GURUCEAGA, Elisabeth, ESTEBAN, Emilio, SUAREZ, Cristina, CASTELLANO, Daniel, GONZÁLEZ DEL ALBA, Aránzazu, LOZANO, Maria dolores, CARLES, Joan, CLIMENT, Miguel angel, ARRANZ, José ángel, GALLARDO, Enrique, PUENTE, Javier, BELLMUNT MOLINS, Joaquim, GURPIDE, Alfonso, LOPEZ-PICAZO, Jose maria, GONZALEZ HERNANDEZ, Alvaro, MELLADO GONZÁLEZ, Begoña, MARTÍNEZ, Esther, MORENO, Fernando, FONT POUS, Albert, CALVO, Alfonso. Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma. _PLoS One_. 2014. Vol. 9, núm. 1, pàgs. e86263-e86263. [consulta: 20 de gener de 2026]. ISSN: 1932-6203. [Disponible a: https://hdl.handle.net/2445/121365]